ATR enforcement of the S/G2 checkpoint prevents premature S phase shutdown and genome instability

Melissa J. McEvoy, Joshua C. Saldivar
2026 · doi:10.64898/2026.05.07.723638
preprint OA: closed CC-BY-NC-4.0
🔓 Open OA copy View at publisher

Abstract

The ATR-enforced S/G2 checkpoint activates during DNA replication to restrain CDK1-dependent phosphorylation of FOXM1 and subsequent transactivation of the G2/M gene network until the end of S phase. However, the extent to which this checkpoint ensures the completion of DNA replication and whether it safeguards genomic integrity has remained unknown. Here, we induce S/G2 checkpoint failure throughout S phase in non-malignant human epithelial cells using multiple ATR pathway inhibitors. Consequently, the mitotic kinase complex cyclin B1-CDK1 prematurely shuts-down the DNA replication program, preventing the completion of genome duplication. In turn, this leads to the retention of inactive replisomes on chromatin and unfired origins into the G2 phase, which induce subsequent accumulation of pan-nuclear ᵧH2AX and mitotic failure. Collectively, these findings indicate the S/G2 checkpoint ensures replication completion and genome stability.

My notes (saved in your browser only)

Funding

funders
[{'doi': '10.13039/100000057', 'name': 'National Institute of General Medical Sciences', 'awards': ['R35GM147710']}, {'doi': None, 'name': 'Office of Research Infrastructure Programs', 'awards': ['S10OD034224']}]

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (36)

Source provenance

crossref
last seen: 2026-06-04T01:00:26.223368+00:00
europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-NC-4.0